Publicacións nas que colabora con Ricardo Blanco Alonso (62)

2019

  1. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

2018

  1. Cardiovascular risk stratification in axial spondyloarthritis: Carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 73-80

  2. Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound

    Arthritis Research and Therapy, Vol. 20, Núm. 1

  3. Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis

    International Journal of Rheumatology, Vol. 2018

2017

  1. Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis

    Scientific Reports, Vol. 7

2016

  1. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers

    Autoimmunity Reviews, Vol. 15, Núm. 11, pp. 1013-1030

  2. Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: Results of a population-based study

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 5, pp. 885-892

  3. Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis

    Scientific Reports, Vol. 6

  4. Subclinical atherosclerosis is not increased in patients with non-radiographic axial spondyloarthritis

    Clinical and Experimental Rheumatology

  5. The framingham score and the systematic coronary risk evaluation at low cutoff values are useful surrogate markers of high-risk subclinical atherosclerosis in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 43, Núm. 3, pp. 486-494

  6. Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 245, pp. 139-142

2015

  1. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients

    Rheumatology International, Vol. 35, Núm. 12, pp. 2069-2078

  2. Atherosclerotic disease in axial spondyloarthritis: Increased frequency of carotid plaques

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 3, pp. 315-320

  3. Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: A cross-sectional study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  4. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis

    BioMed Research International, Vol. 2015

  5. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis

    Journal of Rheumatology, Vol. 42, Núm. 1, pp. 39-45

  6. Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients

    PLoS ONE, Vol. 10, Núm. 11

  7. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 491-497

2014

  1. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis

    BioMed Research International, Vol. 2014

  2. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases